Stockscreener 앱 받기
7.64
5.21%
-0.42
전일 마감가:
$8.06
열려 있는:
$8.05
하루 거래량:
606.89K
Relative Volume:
1.06
시가총액:
$236.85M
수익:
-
순이익/손실:
$-29.25M
주가수익비율:
-6.4418
EPS:
-1.186
순현금흐름:
$-22.80M
1주 성능:
-7.28%
1개월 성능:
+4.80%
6개월 성능:
+99.48%
1년 성능:
+40.96%
1일 변동 폭
$7.64
$8.1444
1주일 범위
$7.69
$8.624
52주 변동 폭
$1.73
$11.41
Sagimet Biosciences Inc Stock (SGMT) Company Profile
명칭
Sagimet Biosciences Inc
전화
(650) 561-8600
주소
155 BOVET RD., SUITE 303, SAN MATEO
SGMT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SGMT
Sagimet Biosciences Inc
|
7.64 | 262.12M | 0 | -29.25M | -22.80M | -1.186 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.76 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.28 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.50 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.22 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.78 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Sagimet Biosciences Inc Stock (SGMT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-11 | 개시 | Wedbush | Outperform |
| 2025-08-07 | 재개 | H.C. Wainwright | Buy |
| 2025-07-24 | 개시 | Canaccord Genuity | Buy |
| 2024-12-06 | 개시 | Oppenheimer | Outperform |
| 2024-11-12 | 개시 | UBS | Buy |
| 2024-06-28 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-05-02 | 개시 | H.C. Wainwright | Buy |
| 2024-03-25 | 개시 | Leerink Partners | Outperform |
| 2023-08-08 | 개시 | Goldman | Buy |
| 2023-08-08 | 개시 | JMP Securities | Mkt Outperform |
| 2023-08-08 | 개시 | Piper Sandler | Overweight |
| 2023-08-08 | 개시 | TD Cowen | Outperform |
모두보기
Sagimet Biosciences Inc 주식(SGMT)의 최신 뉴스
What catalysts could drive Sagimet Biosciences Inc. stock higherMarket Sentiment Review & Fast Gain Stock Trading Tips - newser.com
Is Sagimet Biosciences Inc. (0O2) stock worth holding before Fed meeting2025 Top Decliners & Technical Buy Zone Confirmations - newser.com
How sustainable is Sagimet Biosciences Inc. stock dividend payoutPortfolio Value Report & Reliable Price Breakout Alerts - newser.com
How Sagimet Biosciences Inc. stock compares to market leadersWeekly Trading Summary & Stock Portfolio Risk Control - newser.com
How cyclical is Sagimet Biosciences Inc. (0O2) stock compared to rivalsMarket Volume Summary & AI Driven Stock Movement Reports - newser.com
Will Sagimet Biosciences Inc. rebound enough to break even2025 Volume Leaders & Accurate Technical Buy Alerts - newser.com
Why Sagimet Biosciences Inc. (0O2) stock attracts wealthy investors2025 Price Targets & Daily Market Momentum Tracking - newser.com
Relative strength of Sagimet Biosciences Inc. in sector analysisWeekly Trading Summary & Fast Gaining Stock Reports - newser.com
Chart based exit strategy for Sagimet Biosciences Inc.July 2025 Fed Impact & Verified Momentum Watchlists - newser.com
Is Sagimet Biosciences Inc. stock resilient to inflation2025 Market Overview & Growth Focused Investment Plans - newser.com
Sagimet Biosciences Inc. (NASDAQ:SGMT) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Quantitative breakdown of Sagimet Biosciences Inc. recent moveAnalyst Downgrade & Risk Managed Investment Signals - newser.com
How Sagimet Biosciences Inc. (0O2) stock trades after earnings2025 Bull vs Bear & Technical Pattern Based Buy Signals - newser.com
How Sagimet Biosciences Inc. stock performs in interest rate cyclesJuly 2025 Trade Ideas & AI Based Buy and Sell Signals - newser.com
Can Sagimet Biosciences Inc. (0O2) stock attract analyst upgrades2025 Earnings Impact & Low Volatility Stock Recommendations - newser.com
Key metrics from Sagimet Biosciences Inc.’s quarterly dataWeekly Gains Report & Reliable Intraday Trade Plans - newser.com
How Sagimet Biosciences Inc. stock benefits from global expansion2025 Stock Rankings & Precise Swing Trade Entry Alerts - newser.com
Identifying reversal signals in Sagimet Biosciences Inc.Analyst Downgrade & Long Hold Capital Preservation Tips - newser.com
Will Sagimet Biosciences Inc. stock deliver shareholder valueWeekly Stock Report & Community Consensus Stock Picks - newser.com
Sagimet Biosciences Inc. $SGMT Shares Sold by Dumac Inc. - MarketBeat
Why Sagimet Biosciences Inc. (0O2) stock is a strong analyst pickJuly 2025 Sector Moves & Risk Controlled Stock Alerts - newser.com
What does recent volatility data suggest for Sagimet Biosciences Inc.2025 Top Gainers & Smart Swing Trading Techniques - newser.com
Published on: 2025-10-31 03:58:37 - newser.com
Regression analysis insights on Sagimet Biosciences Inc. performance2025 Top Decliners & Step-by-Step Swing Trade Plans - newser.com
Published on: 2025-10-29 21:31:53 - newser.com
Will Sagimet Biosciences Inc. stock maintain dividend yieldJuly 2025 Selloffs & Capital Protection Trade Alerts - fcp.pa.gov.br
Reversal indicators forming on Sagimet Biosciences Inc. stockJuly 2025 Selloffs & Accurate Technical Buy Alerts - newser.com
Sagimet Biosciences Inc (SGMT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Sagimet Biosciences Inc 주식 (SGMT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Martins Eduardo Bruno | Chief Medical Officer |
Jul 21 '25 |
Sale |
9.13 |
8,277 |
75,607 |
106,936 |
| Rozek Elizabeth | General Counsel and CCO |
Jul 21 '25 |
Sale |
9.13 |
10,780 |
98,471 |
183,726 |
1.29%
0.56%
자본화:
|
볼륨(24시간):